<DOC>
	<DOCNO>NCT00569504</DOCNO>
	<brief_summary>The purpose study ass cross-sectional prevalence metabolic syndrome patient schizophrenia take antipsychotic .</brief_summary>
	<brief_title>Prevalence Metabolic Syndrome SPR Taking Antipsychotics</brief_title>
	<detailed_description>Schizophrenic patient take kind antipsychotic least 1 year Seoul National Hospital participate study . plan enroll approximately 1000 patient schizophrenia . For subject - abdominal circumference - body mass index - lipid profile : TG , HDL-chlo , total chol - systolic/diastolic blood pressure - fasting blood glucose measure . calculate rate patient meet criterion Metabolic syndrome . 1 . Abdominal obesity : absolute criterion 2 . 2 following 1 . Triglyceride ≥ 150mg/dL ongoing treatment 2 . HDL-cholesterol ＜ 40mg/dL ( men ) HDL-cholesterol ＜ 50mg/dL ( female ) ongoing treatment 3 . Hypertension 130mmHg ≥ systolic 85mmHg ≥ diastolic ongoing treatment 4 . FBS ≥ 100mg/dL previous diagnosis type II DM</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Patients take antipsychotic least one year schizophrenia schizoaffective disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>prevalence</keyword>
</DOC>